N/A
N=41
Youth Power Action Feasibility Study of Online Support Group Intervention Among Adolescents Living With HIV in Nigeria
HIV/AIDS · Adolescent Behavior · Medication Adherence · Health Behavior
Bottom Line
View on ClinicalTrials.gov: NCT03076996 ↗Enrolled (actual)
41
Serious AEs
0.0%
Results posted
Feb 2019
Primary outcome: Primary: Percentage of Active Members Who Have at Least One Post in Group Chat Session. — 32 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Online support group (Behavioral)
- Age
- Pediatric, Adult · 15+ yrs
- Sex
- All
- Sponsor
- FHI 360
- Primary completion
- Jan 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Active Members Who Have at Least One Post in Group Chat Session. |
32 | — |
| SECONDARY Acceptability Score |
9.9 | — |
| SECONDARY Adherence to ART as Measured by the AACTG Adherence Assessment |
29 | — |
| SECONDARY Adherence to Follow-up Visit Within 1 Month of Scheduled Date |
37 | — |
Summary
This study will examine the feasibility and acceptability of an intervention designed to improve retention in HIV care services and improve anti-retroviral therapy (ART) adherence among adolescents ages 15-19 years living with HIV enrolled in ART services.
Eligibility Criteria
Inclusion Criteria
- HIV positive and currently on ART for at least 6 months
- Age 15 to 19 years
- Can demonstrate basic literacy necessary to participate in online chats
Exclusion Criteria
- Not planning to remain in the study area (within Akwa Ibom State) for the duration of the study (approximately 6 months)
- Currently enrolled in an in-person support group
- Currently enrolled in another research study related to HIV service retention or ART adherence
- Critically or severely ill requiring hospitalization or such that the individual is unable to provide informed consent at the time of study recruitment
Data sourced from ClinicalTrials.gov (NCT03076996). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.